Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. - Test2 - elhamkhani - TriplyDB

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

http://www.wikidata.org/entity/Q33888431

about

Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.Tumour class prediction and discovery by microarray-based DNA methylation analysis HLTF gene silencing in human colon cancer.The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas Identification and characterization of the potential promoter regions of 1031 kinds of human genes Therapeutic Implications of Targeting AKT Signaling in Melanoma Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer Epigenetics as a mechanism driving polygenic clinical drug resistance Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands Genetic alteration and gene expression modulation during cancer progression Characteristic promoter hypermethylation signatures in male germ cell tumors Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome Suppression of metallothionein-I/II expression and its probable molecular mechanisms Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role Cytosine modifications in neurodevelopment and diseases Epigenetics advancing personalized nanomedicine in cancer therapy miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Epigenetics in Cancer: A Hematological Perspective Epigenetics and Common Ophthalmic Diseases Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Epigenetic silencing of the HIC-1 gene in human medulloblastomas Global methylation profiling of lung cancer identifies novel methylated genes Methylation matters 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal Recurrent epimutations activate gene body promoters in primary glioblastoma Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation

P2860

Q21092374-0F1F6FA6-406A-465F-A0E1-6B7EA49232C8 Q21146392-DC9A5C6B-1300-4133-A011-BDC5ADEAB5F8 Q21245768-7309C7B2-D7D8-446A-BD43-A32AEBAD14FA Q21246015-04BBA3A0-DD5C-4B1B-9E07-B3E6C510DA7C Q24514903-93B11FCF-1899-4A34-8CA7-669CE0F958C4 Q24536137-29441F76-251F-46B2-B427-8ABA9C2B53E5 Q24536177-E38766B3-CE04-4684-9091-6BB7AE8436E7 Q24536837-AE790E95-0D9D-4245-8E9F-99705052058E Q24538785-9FEAC6EA-A1E1-4523-AE26-8E177CB5FEF9 Q24550860-4C09F5DA-7D35-4F4F-A001-411762D5B3B6 Q24619773-31368093-036D-48EF-86CA-B382F967784F Q24631438-99552178-E63F-4F3B-B8B6-1BD1927A35C3 Q24643488-AC242F8E-AC0B-430A-9488-6211FB311756 Q24651640-ABA7DFFF-157A-4718-83D7-832AB0242044 Q24652017-258A1BA4-FFC6-457D-9549-6AC805C6E8A9 Q24657474-1BC0816A-958F-40F9-98CB-B2F1235545A1 Q24679642-DEC4575A-E30A-4483-8A0F-FF540A908121 Q24682438-600E934D-2B62-4F9D-BFA8-9AA263088006 Q24798750-74E1584A-9A76-471B-B9B9-BB885CDD0ACA Q24799928-1AAAD134-A62E-45DE-A0B8-C82D2487850B Q24800480-F5838280-3D4F-409E-92D1-5B6BB30B8478 Q24812578-86F305BB-1F34-4796-B53D-D5B068F2791A Q26827297-F339C669-35EB-42FE-BEFA-DC2FF6A4F239 Q26852086-69E4C027-B252-4C1F-B1A6-E08C713A7A39 Q26852087-D46ADD92-C50E-4CD0-A8DA-B9BBC5D364CB Q27010637-A00643CD-5EE5-4A68-B6ED-3697474936D6 Q27023295-F84866B5-DC85-446A-854F-1CEC5DD6597A Q28077082-08BEAFDB-EB0A-4487-9E4D-65F30C789503 Q28077626-71F8BF0F-9A23-4DF0-8AD1-23505070BDE3 Q28087759-F762584F-F224-403C-B9D4-A092F24E77C5 Q28189231-65470B76-2909-4B7D-96B7-4B0E62029373 Q28360366-2B69D12E-E5AA-4B4D-BB0E-DCB472B3B12A Q28364163-8D580074-6E80-4908-A1B3-7D91143AA2F5 Q28384242-99751610-017B-4108-A2F9-DCDEA963DBB5 Q28385236-A05CE796-9885-4340-B5F7-86E98C0E6EC6 Q28394142-EF4C32F5-5A6B-4CA4-9FFE-C76DED5CF9F8 Q28469084-2CAB2153-0DCE-4A4D-8A87-C3659672364A Q28475023-9F87BAE9-B232-4904-A3D7-2089FA8274F2 Q28544885-C64234EC-B0FD-4FD4-9410-F07B35ACDEC7 Q28554451-218BEDE1-2B7F-4CFE-9FB0-71DE1C5294CB

P2860

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

http://www.wikidata.org/entity/Q33888431

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@ast

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@en

type

label

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@ast

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@en

prefLabel

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@ast

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

@en

P1433

Q33888431-D0E048AC-6531-4F6C-AF83-4443F27CB66A

P1476

Q33888431-0EFDE264-F680-4407-BC84-0DBBED539DE6

P2093

Q33888431-1D4B4454-91F9-48E5-B3BB-A22D0EF7BE71

Q33888431-26C5C8D1-3280-4B80-BB53-6FC5619758A1

Q33888431-413C727C-D8F7-427C-AC3B-02934729E6D0

Q33888431-46AA4CE2-B402-43E4-B008-DDA9238E3552

Q33888431-49DF37A9-070B-4033-8C3F-461AA4182A23

Q33888431-5F9FE77B-38CF-44C4-94A1-B982ACAD9B4B

Q33888431-70DAB24F-689C-4AED-9A82-259881C0ED08

Q33888431-7144F5B2-0134-49B6-9B38-7C316F2C4982

Q33888431-79C27D21-6FF8-4374-BB74-D93849776207

Q33888431-8294A082-5B88-4FB0-BC59-5C8CB73E3773

P2888

Q33888431-36084CDA-4B9F-42EA-8E3E-0552257ACF38

P304

Q33888431-C733F6B1-BE1B-4EB6-9EDD-EA72DCF9D65D

P31

Q33888431-952008FC-8764-4D3B-AD51-EA66456AF5C0

P356

Q33888431-96FBF46D-136D-4183-9AE5-6617135E4381

P407

Q33888431-9BA13535-336B-477F-957B-3207758B3DFE

P433

Q33888431-9365AE16-83AC-4FB4-8A39-4EA41E4BB6AE

P478

Q33888431-1E6EE119-5385-419C-BBD0-FB3D1DDB7272

P50

Q33888431-1B5EEAAC-94F4-4361-843A-D1F8E1B24647

Q33888431-58AEA0BF-7B29-47CB-A2AD-8C6441C6BAEE

Q33888431-B92664DE-1FE7-4965-BBA8-6E1B0074052F

P577

Q33888431-BC48F955-B76F-472F-8896-6356E7759895

P5875

Q33888431-BBF99D1B-B0E6-4FE0-97A3-E6B5967596A4

P698

Q33888431-66B36E72-3E63-42B6-BA89-D7ACBBB7F9A6

P356

P1433

Nature Genetics

P1476

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns

@en

P2093

Bloomfield CD

http://www.w3.org/2001/XMLSchema#string

Caligiuri MA

http://www.w3.org/2001/XMLSchema#string

Cavenee WK

http://www.w3.org/2001/XMLSchema#string

Costello JF

http://www.w3.org/2001/XMLSchema#string

Feramisco JD

http://www.w3.org/2001/XMLSchema#string

Frühwald MC

http://www.w3.org/2001/XMLSchema#string

Gao X

http://www.w3.org/2001/XMLSchema#string

Held WA

http://www.w3.org/2001/XMLSchema#string

Lang JC

http://www.w3.org/2001/XMLSchema#string

Nishikawa R

http://www.w3.org/2001/XMLSchema#string

P2888

P304

132-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/72785

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Dominic J. Smiraglia

Gavin P. Robertson

M Sue O'Dorisio

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12659855

http://www.w3.org/2001/XMLSchema#string

P698

10655057

http://www.w3.org/2001/XMLSchema#string